Modern Diagnostic & Research Centre Ltd
Complete IPO details, including price band, financials, subscription status, and key insights.
Participate in the Modern Diagnostic & Research Centre Ltd IPO with full transparency. Review issue details, company fundamentals, and financial performance, and apply securely through Alice Blue.
IPO Snapshot
Key metrics and details at a glance.
Price Band
₹90
Per ShareLot Size
1600 Shares
Minimum Investment
₹1,44,000
Issue Size
₹36.89 Cr
Face Value
₹10
Per ShareIPO Type
Book Building - SME
Retail Quota
35.02%
QIB Quota
49.94%
NII Quota
15.04%
IPO Timeline
Important dates for your applying strategy.
Subscription Status
Live demand across investor categories.
Track real-time subscription levels:
*Real-time data subject to exchange updates
Modern Diagnostic & Research Centre Ltd
Business model, operations, and market positioning.
Promoter Holding (Pre-Issue)
100%
Promoter Holding (Post-Issue)
72.85%
Issue Type
Book Building - SME
ISIN
INE1HK501016
About the Company
The Company is a services provider in diagnostic and related healthcare tests services in India. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory. Through its integrated, nationwide network, the company offers a complete range of diagnostic facilities in radiology and pathology. The Company provides healthcare tests and services for use in core testing, patients' diagnosis and prevention, monitoring of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.
Industry Overview
Diagnostic process is crucial for identifying and managing various health conditions and ensuring effective medical treatment and patient care, thus facilitating faster recovery of patient. Diagnostic companies provide service to clients in both B2B which includes hospitals, nursing homes, clinics, and other healthcare establishments, and B2C which includes direct customers. The diagnostic process in India starts with patients recognizing symptoms or going for routine/wellness checkups. They first consult a doctor who evaluates their condition and recommends specific diagnostic tests. Patients can then proceed by visiting diagnostic centres directly to undergo the tests, providing samples at the doctor's clinic for transfer to the lab, or using home collection services offered by some diagnostic centres. After the samples are collected, the laboratory conducts the necessary tests. Results are then delivered to patients either online or offline, or directly to hospitals for those labs engaged in B2B services. This comprehensive process ensures accurate and timely diagnosis, aiding in effective medical treatment.
Company History
The Company was originally incorporated as "Modern Diagnostic & Research Centre Private Limited" as a private limited company, under the provisions of the Companies Act, 2013 vide Certificate of Incorporation dated April 16, 2012 issued by Registrar of Companies, Delhi having Corporate Identification Number U85110DL2012PTC234368. Subsequently, the Company was converted from a private limited company to public limited company pursuant to special resolution passed in the Extra-Ordinary General Meeting of the company held on November 16, 2024 and consequently the name of the Company was changed to "Modern Diagnostic & Research Centre Limited" pursuant to fresh certificate of incorporation dated December 18, 2024 issued to the Company by the Registrar of Companies, Central Processing Centre having Corporate Identification Number U85110DL2012PLC234368.
Products & Services
- The Company is a services provider in diagnostic and related healthcare tests services in India. It offers a one-stop solution for pathology and radiology testing services such as imaging (including radiology), pathology/clinical laboratory.
Growth Strategy
- Leveraging its market skills and relationship.
- Continue its Focus on Providing Quality Tests and Services.
- Expand its geographical presence.
- Increase the breadth of its diagnostic healthcare testing and services platform.
Customer Base
Wholesaler and Retailer
Financial Performance
Revenue, profit after tax and total assets across the last 3 reported financial years.
Revenue
Amount in ₹ crore
Profit After Tax (PAT)
Amount in ₹ crore
Total Assets
Amount in ₹ crore
Figures in ₹ crore, on a standalone basis, as reported for FY23 to FY25.
Objects of the Issue
How the company plans to utilize IPO proceeds.
Use of Proceeds
The funds raised through this IPO will be used for:
Initial public issue of up to 40,99,200 equity shares of face value of Rs. 10/- each of Modern Diagnostic & Research Centre Limited ("MDRC" or the "Company" or the "Issuer") for cash at a price of Rs. 90 per equity share including a share premium of Rs. 80 per equity share (the "Issue Price") aggregating to Rs. 36.89 crores ("the Issue"), of which 2,06,400 equity shares of face value of Rs. 10/- each for cash at a price of Rs. 90 per equity share including a share premium of Rs. 80 per equity share aggregating to Rs. 1.86 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 38,92,800 equity shares of face value of Rs. 10/- each at a price of Rs. 90 per equity share including a share premium of Rs. 80 per equity share aggregating to Rs. 35.04 crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 27.15% and 25.78%, respectively, of the post issue paid up equity share capital of the company. The face value of the equity shares is Rs. 10/- each. Price Band: Rs. 90/- per equity share of face value Rs. 10/- each. The floor price is 9.00 times of the face value. Bids can be made for a minimum of 3200 equity shares and in multiples of 1600 equity shares thereafter.
*Subject to approvals and market conditions.
Strengths & Risks
Key competitive advantages and factors to consider before investing.
- Experienced Promoter and Management Team.
- Comprehensive diagnostics provider delivering all-in-one solution at cost-effective prices.
- Focus on quality and customer service.
- Centralized information technology platform.
- Any interruptions at its laboratories and diagnostic centres may affect the company's ability to process diagnostic tests, which in turn may adversely affect its business, results of operations and financial condition.
- The company's business and prospects may be adversely affected if the company is unable to maintain and grow its brand name and brand image.
- Majority of the company's operations are concentrated in state of Haryana and any adverse developments affecting Haryana could have an adverse effect on its business, results of operations and financial condition.
- The company has certain outstanding litigation against us, an adverse outcome of which may adversely affect its business, reputation and results of operations.
- There may be significant dependence on key diagnostic equipment and core technology infrastructure, the failures of which could result in serious service disruptions.